Intuitive Surgical (NASDAQ:ISRG) Given New $500.00 Price Target at Mizuho

Intuitive Surgical (NASDAQ:ISRG) had its price objective raised by Mizuho from $440.00 to $500.00 in a research report released on Thursday morning, Marketbeat Ratings reports.

A number of other equities analysts have also recently issued reports on the stock. Barclays upped their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Piper Sandler upped their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Evercore ISI raised their price target on shares of Intuitive Surgical from $410.00 to $475.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Raymond James upped their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Finally, BTIG Research increased their price objective on Intuitive Surgical from $494.00 to $518.00 and gave the company a “buy” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Stock Performance

ISRG stock opened at $521.15 on Thursday. The firm has a 50 day moving average price of $483.85 and a 200-day moving average price of $438.56. Intuitive Surgical has a 52-week low of $254.85 and a 52-week high of $523.34. The firm has a market capitalization of $184.85 billion, a price-to-earnings ratio of 94.07, a PEG ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the previous year, the business earned $1.18 earnings per share. The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical will post 5.22 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $5,441,507.50. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock valued at $25,528,753 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently made changes to their positions in ISRG. NBC Securities Inc. boosted its holdings in shares of Intuitive Surgical by 34.4% during the 1st quarter. NBC Securities Inc. now owns 121 shares of the medical equipment provider’s stock valued at $48,000 after purchasing an additional 31 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its holdings in Intuitive Surgical by 7.8% during the 1st quarter. Massmutual Trust Co. FSB ADV now owns 930 shares of the medical equipment provider’s stock valued at $371,000 after buying an additional 67 shares in the last quarter. Montecito Bank & Trust bought a new stake in Intuitive Surgical in the 1st quarter worth approximately $324,000. Signal Advisors Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $203,000. Finally, Fulton Bank N.A. boosted its position in shares of Intuitive Surgical by 13.5% during the 1st quarter. Fulton Bank N.A. now owns 2,528 shares of the medical equipment provider’s stock valued at $1,009,000 after acquiring an additional 301 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.